Unknown PHASE4 INTERVENTIONAL 1-arm NCT03486561

Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) (MIDA)

Sponsor: OBS Pakistan

Interventions Ranolazine

Updated 6 times since 2018 Last updated: Mar 31, 2018 Started: Apr 1, 2018 Primary completion: Sep 30, 2018 Completion: Oct 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Chronic Stable Angina and is currently ongoing. OBS Pakistan leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Apr 2020 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Apr 2020 [monthly]

Not Yet Recruiting PHASE4

▶ Show 1 earlier version

May 2018 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

OBS Pakistan

Data source: OBS Pakistan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.